Factors Affecting Recanalization in Femoropopliteal Deep Vein Thrombosis
Open Access
- 1 January 2023
- journal article
- research article
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 29
Abstract
Effects of warfarin and new-generation direct oral anticoagulants (DOACs) on thrombus resolution after the treatment of deep vein thrombosis (DVT) are still unknown. The study aimed to investigate the effects of warfarin and DOACs on thrombus resolution after DVT treatment. Methods: The study included 666 patients who were diagnosed with femoropopliteal DVT between January 2016 and January 2022 and had complete medical records without missing data. Patients with and without recanalization were added to groups 1 (n = 396) and 2 (n = 270), respectively. Ultrasonography/venous Doppler examinations of the patients during follow-up were performed by 3 radiologists. Recanalization was defined as the presence of complete flow in the femoral and popliteal veins and the absence of residual venous thrombus. Results: Among the included patients, recanalization was observed in 59.5% patients. The mean follow-up period was 23.6 ± 17.8 (range 1-72; median 17) months. There was no difference between the 2 groups in terms of the types of drugs used in the treatment ( P = .208). Cox regression models were used to investigate the factors affecting recanalization. Analysis of the variables having significant differences between both groups revealed the low rate of recanalization in patients with coronary artery disease (odds ratio [OR], 2.3%; 95% confidence intervals [CI]: 1.6-3.4; P < .001) and diabetes mellitus (OR, 1.5; 95% CI: 1.1-1.9; P = .009). Conclusion: Thrombus resolution after femoropopliteal DVT is not affected by the drugs used in the treatment.Keywords
This publication has 20 references indexed in Scilit:
- Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulantsThrombosis Research, 2017
- Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE programThrombosis Journal, 2015
- A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysisThrombosis Journal, 2015
- Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939)Circulation, 2007
- Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolismJournal of Thrombosis and Haemostasis, 2006
- Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health StudyJournal of Thrombosis and Haemostasis, 2006
- Decrease in sensitivity of D-dimer for acute venous thromboembolism after starting anticoagulant therapyBlood Coagulation & Fibrinolysis, 2002
- The occurrence of the post-thrombotic changes after an acute deep venous thrombosis. A prospective two-year follow-up study.2000
- The Long-Term Clinical Course of Acute Deep Venous ThrombosisAnnals of Internal Medicine, 1996
- Thrombus regression in deep venous thrombosis. Quantification of spontaneous thrombolysis with duplex scanning.Circulation, 1992